| J Adam Martin Chiropractic Llc | |
|
512 E Main St, New Albany, MS 38652-4915 | |
| (662) 534-6330 | |
| (662) 534-7418 |
| Full Name | J Adam Martin Chiropractic Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 512 E Main St, New Albany, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033530159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 0800 (Mississippi) | Primary |
| Provider Name | Joseph A Martin |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1851481451 PECOS PAC ID: 7618104050 Enrollment ID: I20131211000335 |
News Archive
Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.
A team led by scientists at The Scripps Research Institute has identified a long-sought protein that facilitates one of the most basic functions of cells: regulating their volume to keep from swelling excessively.
A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function.
Boston Scientific Corporation (NYSE: BSX) has expanded the launch of its S-ICD System into parts of Asia. The first implant of the S-ICD System in Asia was performed in Hong Kong by Prof. Hung Fat Tse, Professor of Cardiovascular Medicine, The University of Hong Kong and Department of Medicine, Queen Mary Hospital in Pokfulam, Hong Kong, under the proctorship of Dr. Martin Stiles, Director of Electrophysiology, Waikato Hospital in Hamilton, New Zealand.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| J Adam Martin Chiropractic Llc 512 E Main St, New Albany, MS 38652-4915 Ph: (662) 534-6330 | J Adam Martin Chiropractic Llc 512 E Main St, New Albany, MS 38652-4915 Ph: (662) 534-6330 |
News Archive
Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.
A team led by scientists at The Scripps Research Institute has identified a long-sought protein that facilitates one of the most basic functions of cells: regulating their volume to keep from swelling excessively.
A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function.
Boston Scientific Corporation (NYSE: BSX) has expanded the launch of its S-ICD System into parts of Asia. The first implant of the S-ICD System in Asia was performed in Hong Kong by Prof. Hung Fat Tse, Professor of Cardiovascular Medicine, The University of Hong Kong and Department of Medicine, Queen Mary Hospital in Pokfulam, Hong Kong, under the proctorship of Dr. Martin Stiles, Director of Electrophysiology, Waikato Hospital in Hamilton, New Zealand.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
› Verified 6 days ago
Dr. Logan Gates, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 512 E Main St, New Albany, MS 38652 Phone: 662-534-6330 | |
Dr. Micheal Gregory Medlin, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 132 W Bankhead St Ste B, New Albany, MS 38652 Phone: 662-534-6636 Fax: 662-534-6639 | |
Knighton Chiropractic And Wellness Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 512 E Main St, New Albany, MS 38652 Phone: 662-534-6330 Fax: 662-534-7418 | |
Medlin Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 132 W Bankhead St Ste B, New Albany, MS 38652 Phone: 662-534-6636 Fax: 662-534-6639 | |
Frontier Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 125 Main St W, New Albany, MS 38652 Phone: 662-539-7079 Fax: 662-539-7119 | |
Dr. Logan Gates, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 512 E Main St, New Albany, MS 38652 Phone: 662-534-6330 |